Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (AVHHL) Cash & Current Investments (2019 - 2025)

Historic Cash & Current Investments for AVITA Medical (AVHHL) over the last 7 years, with Q4 2025 value amounting to $22.0 million.

  • AVITA Medical's Cash & Current Investments fell 4996.47% to $22.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $22.0 million, marking a year-over-year decrease of 4996.47%. This contributed to the annual value of $22.0 million for FY2025, which is 4996.47% down from last year.
  • Per AVITA Medical's latest filing, its Cash & Current Investments stood at $22.0 million for Q4 2025, which was down 4996.47% from $23.3 million recorded in Q3 2025.
  • AVITA Medical's Cash & Current Investments' 5-year high stood at $115.1 million during Q1 2021, with a 5-year trough of $15.7 million in Q2 2025.
  • In the last 5 years, AVITA Medical's Cash & Current Investments had a median value of $70.8 million in 2023 and averaged $66.0 million.
  • As far as peak fluctuations go, AVITA Medical's Cash & Current Investments skyrocketed by 5025.33% in 2021, and later plummeted by 7097.45% in 2025.
  • Over the past 5 years, AVITA Medical's Cash & Current Investments (Quarter) stood at $85.4 million in 2021, then dropped by 7.05% to $79.3 million in 2022, then grew by 12.24% to $89.1 million in 2023, then tumbled by 50.65% to $44.0 million in 2024, then tumbled by 49.96% to $22.0 million in 2025.
  • Its last three reported values are $22.0 million in Q4 2025, $23.3 million for Q3 2025, and $15.7 million during Q2 2025.